Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

Stock Information for Codexis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Codexis Inc.

Codexis Announces Signing of Lease for GMP Manufacturing Facility
Codexis Reports Third Quarter 2025 Financial Results
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
Codexis to Report Third Quarter 2025 Financial Results on November 6
Codexis to Participate in Cantor Global Healthcare Conference
Codexis to Report Second Quarter 2025 Financial Results on August 13
Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
Codexis to Participate in Jefferies Global Healthcare Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.